How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer. [electronic resource]
Producer: 20090928Description: 414-21 p. digitalISSN:- 1472-4146
- Adenocarcinoma, Follicular -- drug therapy
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Papillary -- drug therapy
- DNA, Mitochondrial -- genetics
- Gene Rearrangement
- Humans
- Mutation
- Proto-Oncogene Proteins B-raf -- genetics
- Proto-Oncogene Proteins c-ret -- genetics
- Thyroid Neoplasms -- drug therapy
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.